Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022)
Tilray Brands (TLRY) reported Depreciation & Amortization (CF) of $34.1 million for Q3 2022, down 13.38% on a YoY basis from $39.3 million in Q3 2021, and down 16.43% quarter-over-quarter from $40.8 million in Q2 2022.
Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022) Analysis & Trends
Tilray Brands has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $34.1 million in Q3 2022.
- For the quarter ending Q3 2022, Depreciation & Amortization (CF) fell 13.38% year-over-year to $34.1 million; the trailing twelve-month figure through May 2023 stood at $34.1 million (down 77.96% YoY), and the FY2022 full-year result was $154.6 million, up 127.9% from the prior year.
- Depreciation & Amortization (CF) for Q3 2022 stood at $34.1 million, down from $40.8 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $40.8 million in Q2 2022, with the low at $479000.0 in Q1 2018.
- Historically, Depreciation & Amortization (CF) has averaged $16.7 million across 5 years, with a median of $11.5 million in 2020.
- Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) jumped 552.55% — and 2022, when it declined 13.38%.
- Tilray Brands' Depreciation & Amortization (CF) stood at $2.9 million in 2018, then soared by 113.35% to $6.3 million in 2019, then soared by 91.61% to $12.0 million in 2020, then jumped by 211.45% to $37.5 million in 2021, then slipped by 9.08% to $34.1 million in 2022.
- The last three Depreciation & Amortization (CF) figures came in at $34.1 million (Q3 2022), $40.8 million (Q2 2022), and $37.0 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 7.20 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 497,000.00 |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2022 | 34.07 Mn |
| Aug 31, 2022 | 34.07 Mn |
| May 31, 2022 | 40.77 Mn |
| May 31, 2022 | 40.77 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Aug 31, 2021 | 39.33 Mn |
| Aug 31, 2021 | 39.33 Mn |
| May 31, 2021 | 24.54 Mn |
| May 31, 2021 | 24.54 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Aug 31, 2020 | 10.98 Mn |
| Aug 31, 2020 | 10.98 Mn |
| May 31, 2020 | 25.21 Mn |
| May 31, 2020 | 25.21 Mn |
| Mar 31, 2020 | 4.56 Mn |
| Mar 31, 2020 | 4.56 Mn |